Oklahoma becomes the 37th state to implement Medicaid expansion. There’s more consolidation in the home health space. And an independent analysis finds Biogen’s Alzheimer's drug would be cost-effective if priced seven times less than the company’s list price.
Hosted on Acast. See acast.com/privacy for more information.
